CPHI Europe: Gummies as a drug delivery system could improve compliance
Pharmaceutical Technology
OCTOBER 10, 2024
At CPHI Europe, an expert discussed the promise of gummies as a drug delivery system and their unique manufacturing challenges.
Drug Delivery Drug Delivery Systems Manufacturing 
Subcutaneous Medications and Drug Delivery Systems
Roots Analysis
FEBRUARY 26, 2024
Biologics constitute a majority of the top selling drugs and represent one of the fastest growing segments of the overall pharmaceutical industry. In fact, the share of biologics in the overall pharmaceutical contract manufacturing market has increased from 16% in 2006 to over 25% in 2017.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Intranasal Therapeutics and Drug Delivery Systems: The Perfect Alternative to Conventional Route of Administration
Roots Analysis
MARCH 1, 2022
Stakeholders Involved in intranasal therapeutics and drug delivery domain. Most of the drugs (55%) are small molecules. Millions of dollars are being invested in funding the initiatives of various players engaged in the intranasal therapeutics and drug delivery domain. Roots Analysis Report. Web: [link].
Liposome: A Novel Drug Delivery System
Roots Analysis
AUGUST 8, 2023
Furthermore, a wide variety of drugs and macromolecules, including DNA , proteins, and imaging agents, can be encapsulated in liposomal vesicles due to their unique ability to entrap both lipophilic and hydrophilic substances. The various therapeutic applications of liposomes in drug delivery have been highlighted in the figure.
Flexible grinding processes for sterile nanopharmaceutical manufacturing
Pharmaceutical Technology
OCTOBER 26, 2022
Nano-based delivery systems are on the rise, as they enable manufacturers to deliver therapeutic agents to specific targeted tissue in a more controlled manner. Data indicates that the global nanopharmaceutical drugs market size reached USD 53.85 Billion in 2021 and is expected to reach USD 102.4 Billion in 2030.
Manufacturing 
130
130 
Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities
Roots Analysis
FEBRUARY 26, 2023
Over the last two decades, the pharmaceutical industry has observed a paradigm shift from conventional drug delivery strategies to the long-acting drug delivery (LADD) of products to treat several disease indications, such as ophthalmic disorders, oncological disorders, neurological disorders and infectious diseases.
Prefilled syringes and vaccines: Optimising parenteral packaging for the next pandemic
Pharmaceutical Technology
NOVEMBER 15, 2022
When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. To boost the profitability of the drug at a later stage in its lifecycle, manufacturers may then consider changing the presentation to prefilled syringes. Lowering extractables levels .
Packaging 130
130 
Hydrocortisone by Antares Pharma for Adrenal Insufficiency: Likelihood of Approval
Pharmaceutical Technology
FEBRUARY 27, 2023
Antares Pharma overview Antares Pharma is a specialty pharmaceutical company engaged in the development, manufacturing, and commercialization of pharmaceutical products and technologies. The company employs drug delivery systems to advance drug compounds and drug delivery methods.
Drug Delivery 100
100 
Leading commercial dose (non-sterile) companies in contract marketing
Pharmaceutical Technology
SEPTEMBER 20, 2022
The information contained within the download document is intended for pharmaceutical manufacturers, wholesalers, retailers and distributors, pharmaceutical executives, medical representatives, business development managers, retail salesmen, sales managers, pharmacy executives, and any other individual involved in pharmaceutical marketing.
Marketing 100
100 
Meeting global demand for patient independence: SHL Medical expands production in Charleston, US
Pharmaceutical Technology
NOVEMBER 7, 2022
SHL Medical is a world-leading solutions provider for advanced drug delivery systems with a unified purpose to further enable patient independence. Currently, SHL Medical has four locations, in Switzerland, Taiwan, Sweden, and the US, with Taiwan being the main manufacturing location.
Production 130
130 
Subcutaneous Biologics: The Unmet Requirement in the Pharmaceutical Space
Roots Analysis
MARCH 21, 2022
However, several drug delivery devices that enable patients to self-administer their respective medications are now available. Subcutaneous drug delivery systems – the helping hand for patients. Examples of some of the most popular types of drug delivery systems have been depicted below.
The Power of Lipids: Enhancing Drug Delivery with Nanoparticles
Roots Analysis
MAY 21, 2024
In addition, NLCs offer benefits such as high drug loading capacity, improved drug retention and avoidance of drug expulsion. Advantages of Lipid Nanoparticle LNPs are gaining significant attention of formulation scientists in drug delivery due to the various advantages offered by them.
Biopharmaceutical Excipient Manufacturing – Current Scenario and Future Trends
Roots Analysis
MARCH 13, 2022
Therefore, a variety of excipients, which are pharmacologically inert substances themselves, are used to stabilize biologics during the manufacturing process and storage. Additionally, biopharmaceutical excipients act as bulking agents, antioxidants or preservatives.
STAT+: Pharmalittle: Moderna must face patent claims over its Covid-19 vaccine; Pfizer and BioNTech testing combo Covid and flu shot
STAT News
NOVEMBER 3, 2022
The companies allege Moderna’s vaccine uses their technology for a drug-delivery system without permission. Citing Lilly announced earlier this year that the creation of its proposed manufacturing campus would create 300 permanent jobs once operational as well as 500 jobs during the construction phase.
Vaccination 97
97 
Accelerating Oligonucleotide Demand: A Force Driving The Contract Manufacturing Market
Roots Analysis
FEBRUARY 24, 2022
The overall manufacturing of oligonucleotides involves the following steps. Owing to the incessant demand for oligonucleotide-based products, several small to mid-sized companies and certain pharma giants, have begun outsourcing their manufacturing operations to contract service providers. Accelerating Oligonucleotide Demand.
A Biodegradable Nanocellulose ECG Patch: The Sustainable Alternative
XTalks
MAY 30, 2023
The healthcare industry has one of the heaviest environmental footprints, and manufacturers are increasingly faced with regulations to make more sustainable products,” said Mohammad H. The patch itself is made of biodegradable nanocellulose and contains no plastic additives. Behfar, senior scientist at VTT, in the news release.
Growing Demand for Oligonucleotides Proposes Shedload of Opportunities for Contract Manufacturers
Roots Analysis
FEBRUARY 18, 2022
The current landscape consists of more than 95 players that claim to offer oligonucleotide contract manufacturing services for research, diagnostic and therapeutic applications. It is worth highlighting that major share of the global oligonucleotide manufacturing capacity is installed in North America, primarily in the US. Web: [link].
Asahi Kasei Providing Samples of Hyaluronic Acid Nanogel as a New Pharmaceutical Excipient
BioTech 365
AUGUST 4, 2020
Advancing toward commercialization as base material for drug delivery systems TOKYO–(BUSINESS WIRE)–Asahi Kasei has established industrial manufacturing technology for hyaluronic acid (HA) nanogel* as a new pharmaceutical excipient, and is providing samples to prospective customers in order to commercialize the … Continue reading (..)
Exosomes: A Deeper Look into Service Providers Market
Roots Analysis
MARCH 16, 2022
In order to promote the use of exosomes in various therapeutic applications including targeted drug delivery vehicles, engineered exosomes and many more, there are a number of companies that offer services related to the isolation, purification, characterization or quantification of exosomes. Want additional details on the pipeline?
Marketing 59
59 
mRNA Synthesis: ManufacturingProcess of Modern Revolutionary Molecule
Roots Analysis
FEBRUARY 13, 2023
As a result, there is an evident increase in the demand for mRNA manufacturing capacity. The key applications of mRNAs are below: Contract Manufacturing in mRNA Synthesis AND Manufacturing Service Domain The synthesis and manufacturing process of mRNA-based therapeutics / vaccines is complex and associated with several challenges.
Nanoparticles: Emerging Stars for Pharmaceutical Industry
Roots Analysis
FEBRUARY 20, 2022
However, manufacturing of these particles is a major challenge for players engaged in the industry. Hence, many pharmaceutical companies outsource manufacturing of nanoparticles to third party organizations, called as contract manufacturers. Nanoparticles Contract Manufacturing. Our Social Media Platform. Web: [link].
Liposomes Development: Service Providers Landscape
Roots Analysis
FEBRUARY 14, 2023
Presently, outsourcing of liposomes development and manufacturing related services has become a popular practice. Drug developers are actively outsourcing their operations to specialized repurposed-based service providers, which are known to have the required capabilities and expertise.
Development 52
52 
Oral Protein / Peptide-based Drugs: Addressing Key Unmet Needs Across Disease Indications
Roots Analysis
MARCH 2, 2022
However, it is important to highlight that there are still several challenges which need to be addressed in order to develop biologic drugs capable of effectively being administered via the oral route without undergoing significant losses in specificity and / or bioavailability. Oral Protein / Peptide-based Drugs. Web: [link].
Protein 52
52 
Shift in the trend of Container closure integrity testing
Roots Analysis
FEBRUARY 16, 2022
In earlier times, container closure integrity testing was not regarded as an essential step in the process of manufacturing. The company developing drug product through such an intense process, use to consider container closure system only for packaging of the product. [1] Container Closure Integrity Testing Services Market.
Containment 52
52 
FDA Encourages Innovation in Medical Device Sterilization While Reducing Adverse Environmental Impacts
XTalks
AUGUST 24, 2022
Nitrogen dioxide sterilization is advantageous for products like drug-delivery systems, pre-filled syringes and other medical devices that encounter challenges with EtO, gamma radiation, or other conventional sterilization techniques. The FDA’s Innovation Challenge 2 is centered on developing strategies to lower EtO emissions.
New Frontiers in Cancer Therapies: Focus on Transcription Factors, GTPases, Phosphatases and GPCRs, 2018-2030
Roots Analysis
FEBRUARY 26, 2024
Roots Analysis – Leaders in Pharmaceutical & Biotechnology Market Research You may also be interested in the following titles: Continuous Manufacturing (Small Molecules and Biologics) Market Subcutaneous Biologics, Technologies and Drug Delivery Systems Market Antibody Discovery Services and Platforms Market Our Social Media Platform Web: (..)
Pharmaceutical Polymers / Medical Polymers -Current Scenario and Future Potential
Roots Analysis
OCTOBER 5, 2023
Driven by the increasing need for safe and efficient medical devices and drug delivery systems, the pharmaceutical polymers / medical grade polymers domain is advancing significantly. There has been a rise in the development of polymers for biopharma with improved biocompatibility, biodegradability and functionality.
To List or Not to List; That is the Question – The FTC Signals the Potential for Greater Scrutiny of Patent Information Submissions to FDA
FDA Law Blog
SEPTEMBER 19, 2023
The six-page statement explains that “Brand drug manufacturers may be harming generic competition through the improper listing of patents in the. But it is not always clear which types of patents are eligible for listing in the Orange Book.
Drugs 105
105 
MYELOID CELL TARGETING THERAPEUTICS: BUDDING THERAPY AGAINST CANCER
Roots Analysis
FEBRUARY 18, 2022
You may also be interested in the following titles: Live Biotherapeutic Products and Microbiome Manufacturing Marke t Next Generation Complement Therapeutics Market Intranasal Therapeutics and Drug Delivery Systems Market. Myeloid Cells Targeting Therapeutics Market. Our Social Media Platform. Web: [link]. Medium: [link].
Prefilled Syringes: Delivering Convenience and Precision in Every Dose
Roots Analysis
JANUARY 17, 2024
They offer several advantages over traditional drug delivery systems ( such as vials and syringes ), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination. Prefilled syringes are syringes that come pre-filled with a specific dose of medication.
Next Generation Complement Therapeutics: Potential Life-Changing Therapies for Multiple Rare Disorders
Roots Analysis
MARCH 3, 2022
You may also be interested in the following titles: Live Biotherapeutic Products and Microbiome Manufacturing Marke t Next Generation Complement Therapeutics Market Intranasal Therapeutics and Drug Delivery Systems Market. Next Generation Complement Therapeutics Market. Our Social Media Platform. Web: [link].
Vivera Pharmaceuticals Announces $440 Million in Backing by JR Dallas Wealth Management
The Pharma Data
NOVEMBER 25, 2020
“Reliable testing and certified personal protective equipment manufactured in the United States plays a key role in the pandemic response and getting our communities back to work. Vivera is vertically integrated with patented technology, manufacturing capabilities, and distribution for its products. .
Rheumatoid arthritis treated with implanted cells that release drug
The Pharma Data
SEPTEMBER 1, 2021
“These cells can sense problems and respond by producing a drug. .” ” The researchers are continuing to experiment with CRISPR-Cas9 and stem cells, even engineering cells that might manufacture more than one drug to respond to different triggers for inflammation. Science Advances, Sept.
Drugs 52
52 
Top Emerging Therapies To Watch Out for in the Retinal Vein Occlusion Market
Delveinsight
NOVEMBER 29, 2020
Therapies such as dexamethasone drug delivery system and vascular endothelial growth factor inhibitors have already pierced deeper into the market. The drug if approved will help minimize the use of unapproved repackaged IV bevacizumab from compounding pharmacists for retinal disease.
Marketing 52
52 
The Streams Have Been Crossed: FTC Enters FDA Territory
FDA Law Blog
NOVEMBER 7, 2023
But there’s no telling what the implicated manufacturers will do, because again, it is legally unclear whether the listing of the device patents is actually anticompetitive. But whether a patent that only claims a device constituent of a combination product has been unclear.
Conjugation and Labeling of Molecules: A Burgeoning Approach in Therapeutics Development and Molecular Imaging
Roots Analysis
SEPTEMBER 13, 2023
Conjugation with a Variety of Molecular Conjugates and Labels The combination of the conjugates / labels with molecules ( proteins, peptides, antibodies and small molecules ) is being used abundantly for several applications, ranging from therapeutics and diagnostics to isolation and characterization of drug delivery systems.
Development 40
40 
Metabolomics: An Emerging yet Powerful Tool in Clinical Research and Development
Roots Analysis
MARCH 24, 2022
You may also be interested in the following titles: Continuous Manufacturing (Small Molecules and Biologics) Market Subcutaneous Biologics, Technologies and Drug Delivery Systems Market Antibody Discovery Services and Platforms Market. Our Social Media Platform. Web: [link]. LinkedIn: [link]. Twitter: [link].
Drugs Companies Clap Back at Congress…Then Get Sued
FDA Law Blog
MARCH 12, 2024
Koblitz — After years of silence from FDA on whether certain patents could be listed in the Orange Book, some manufacturers of drug and device combination products have had a rude awakening lately.
Drugs 45
45 
It Takes a (Global) Village to Manufacture Merck’s Proventil Inhaler
Pharmacy Checkers
NOVEMBER 6, 2020
The more we know about where our meds are made (mostly not here) the less successful drug industry lobbying will be against lower-cost, imported medicines. In some cases, it’s as simple as a drug sold at a U.S. Walgreens is made in a manufacturing facility in one foreign country. Three countries have a hand in making it.
Quality first: How pharma can meet injectables demand while staying compliant
Pharmaceutical Technology
MARCH 22, 2023
The need for quality When it comes to injectable medicine, achieving product sterility through aseptic manufacturing is of critical importance. Primary packaging is relied upon to protect and maintain this sterility across the shelf life of the drug. The manufacturing standard is characterised by a high level of automation.
Contamination 130
130 
Mitigating the risks of cross-contamination during Oral Solid Dose (OSD) manufacturing
Pharmaceutical Technology
FEBRUARY 3, 2023
While the industry is seeing advances in alternative drug delivery systems, oral solid doses, such as pills, capsules and soft gels, remain at the forefront of the industry. Compared to other dosage forms, tablets are simpler to manufacture, package, and transport.
Contamination 130
130 
Leveraging a Drug Patent Portfolio for Success
Drug Patent Watch
DECEMBER 19, 2024
This includes novel drug delivery systems, extended-release formulations, or unique combinations of ingredients that enhance efficacy or reduce side effects. Methods of Treatment These patents protect specific ways of using a drug to treat particular conditions.
Drugs 76
76 
Let's personalize your content